Ora Biomedical
Ora Biomedical, Inc. is a pharmaceutical company utilizing AI and robotics for large-scale longevity interventions discovery.
Founded
2022Ora Biomedical, Inc. is a pharmaceutical company utilizing AI and robotics for large-scale longevity interventions discovery.
Ora Biomedical, Inc. was founded out of the Kaeberlein Lab at the University of Washington with a mission to develop small molecule therapeutics that extend lifespan and delay chronic illness. The company leverages a high-throughput discovery platform, including the WormBot-AI, a robotic system integrated with AI-powered analytics, to identify longevity interventions such as natural products, pharmaceuticals, and small molecule combinations. Ora Biomedical's core vision is to create healthy aging therapies for next-generation medicine.
Notable affiliated individuals include researchers from the Kaeberlein Lab, renowned for their work in aging and longevity. The company has received attention for its innovative approach, particularly the Million Molecule Challenge, which aims to screen vast numbers of compounds for potential therapeutic benefits. Ora Biomedical's impact lies in its potential to revolutionize the field of aging by targeting underlying molecular mechanisms, thereby contributing significantly to the development of therapies that promote healthy aging.
Companies similar to Ora Biomedical include Regenerative Bio, Ordaos, Orchid and Generation Lab.
Ora Biomedical was founded in 2022.
Ora Biomedical's headquarters is located in Seattle, WA, US.
Ora Biomedical's most recent funding round was for $720k (USD) in January 2024.
As of Jan 25, 2024, Ora Biomedical has disclosed funding of $965k (USD). Undisclosed round amounts are excluded.
Ora Biomedical has 30 employees as of Feb 5, 2024.
Generation Lab
generationlab.co
